Lexaria Bioscience Corp. Stock Price - LXRP

Best deals to access real time data!
SMALL CAP PRO
Monthly Subscription
for only
$44.59
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$31.00
SMALL CAP BASIC
Monthly Subscription
for only
$30.03
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Lexaria Bioscience Corp. (QB) LXRP Other OTC Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.07 +4.61% 1.59 1.63 1.42 1.46 1.52 15:59:45
Bid Price Ask Price Spread Spread % News
1.59 1.6 0.01 0.63% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
530 416,503 $ 1.5419 $ 642.2k 358.08k 0.20 - 2.13
Last Trade Time Type Quantity Stock Price Currency
15:58:07 800 $1.59 USD

Lexaria Bioscience Corp. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 110.4M 69.44M $ -1.21M - -90.88 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Lexaria Bioscience Corp. (QB) News

Latest LXRP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXRP Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week1.22.131.151.63491M2M1M0.3932.50%
1 Month0.82.130.721.3556110k2M623k0.7998.75%
3 Months0.446952.130.3221.021229k2M372k1.14305255.74%
6 Months0.29552.130.270.882117k2M219k1.2945438.07%
1 Year0.2052.130.20.644617k2M257k1.385675.61%
3 Years0.082.130.0730.429002M157k1.511,887.50%
5 Years0.04052.130.03250.391502M139k1.54953,825.93%

Lexaria Bioscience Corp. (QB) Description

Lexaria Bioscience Corp. has developed and out-licenses its disruptive technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexarias technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.